Renal Cancer
Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma
January 9, 2018
Body mass index and 20-specific cancers: re-analyses of dose-response meta-analyses of observational studies
January 8, 2018
Quantitative Contour Analysis as an Image-Based Discriminator between Benign and Malignant Renal Tumors
January 8, 2018
The developmental programme for genesis of the entire kidney is recapitulated in Wilms tumour
January 8, 2018
Prognostic value of the Glasgow Prognostic Score for patients with metastatic renal cell carcinoma treated by cytoreductive nephrectomy
January 8, 2018
Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma
January 5, 2018
Pathological upstaging of clinical T1 renal cell carcinoma: an analysis of 115,835 patients from National Cancer Data Base, 2004-2013
January 5, 2018
Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis
January 5, 2018
How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to Know
January 3, 2018
Pathologic analysis of non-neoplastic parenchyma in renal cell carcinoma: a comprehensive observation in radical nephrectomy specimens
January 3, 2018
Cabozantinib: A Multi-targeted Oral Tyrosine Kinase Inhibitor
January 2, 2018
Conversion of Robot Assisted Partial Nephrectomy to Radical Nephrectomy; a Prospective Multi-Institutional Study
January 2, 2018
Individualized dosing with axitinib: rationale and practical guidance
December 29, 2017